Dr. Theresa Werner, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Ovarian Cancer
Studies Gastroesophageal Junction Adenocarcinoma
14 reported clinical trials
23 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
Stage II
2Gastroesophageal Junction Adenocarcinoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Theresa Werner, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
HPV Self-Collection
for Cervical Cancer Prevention
This clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections that last only a few months, but sometimes can last longer. It is known to cause a variety of cancers including cancer of the cervix. Even though there are ways to detect cervical cancer early, many individuals do not undergo screening that involves pelvic exams. Over half of all new cervical cancer cases are among those who have either never been screened or who are not screened enough. Without appropriate screening and care, preventable pre-cancers may turn into cancer. A new way to detect cervical cancer is to have individuals collect their own vaginal sample for HPV testing to know their risk for cervical cancer. This may give individuals more flexibility and comfort having the ability to collect samples themselves, compared to a doctor performing a speculum examination and collecting the samples in a clinic. This study compares clinical accuracy of HPV testing on self-collected vaginal samples versus cervical samples collected by clinician. The Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial is part of the National Cancer Institute (NCI)'s Cervical Cancer 'Last Mile' Initiative, a public private partnership that seeks to increase access to cervical cancer screening. The SHIP Trial focuses on developing clinical evidence to inform the US Food and Drug Administration (FDA)'s regulatory reviews of self-collection approaches as alternative sample collection approaches for cervical cancer screening. Several industry partner-specific self-collection device and assay combinations will be non-competitively and independently evaluated with a similar study design framework to inform pre-approval and/or post-approval regulatory requirements.
Recruiting1 award N/A3 criteria
More about Theresa Werner, MD
Clinical Trial Related2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Theresa Werner, MD has experience with
- Carboplatin
- Letrozole
- Paclitaxel
- Belinostat
- Ribociclib
- Upifitamab Rilsodotin
Breakdown of trials Theresa Werner, MD has run
Ovarian Cancer
Gastroesophageal Junction Adenocarcinoma
Skin Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theresa Werner, MD specialize in?
Theresa Werner, MD focuses on Ovarian Cancer and Gastroesophageal Junction Adenocarcinoma. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Theresa Werner, MD currently recruiting for clinical trials?
Yes, Theresa Werner, MD is currently recruiting for 7 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Theresa Werner, MD has studied deeply?
Yes, Theresa Werner, MD has studied treatments such as Carboplatin, Letrozole, Paclitaxel.
What is the best way to schedule an appointment with Theresa Werner, MD?
Apply for one of the trials that Theresa Werner, MD is conducting.
What is the office address of Theresa Werner, MD?
The office of Theresa Werner, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.